A method for in situ imaging of gene mutations

Through the lighting strategy based on the continuous contact transduction and luminescent RNA aptamers, the high background and signal attenuation problems in intracellular SNVs imaging are solved, and the detection of drug-resistant strains without washing and high contrast is achieved, which is suitable for intestinal sections. Visualization and colonization study of Salmonella.

CN116083534BActive Publication Date: 2024-11-12SICHUAN UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310210105.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-03-07
Publication Date
2024-11-12
Estimated Expiration
2043-03-07

AI Technical Summary

Technical Problem

The prior art is difficult to achieve high contrast single nucleotide point of variation (SNVs) imaging at the cellular level, and due to the binding of nonspecific probes, a strict washing process is required, making it difficult to accurately detect drug-resistant strains.

Method used

Using a lighting strategy based on contact-emitted transcription and luminescent RNA aptamers, SNVs are identified by designing a split probe and combined with the transcribed Broccoli RNA through DFHBI-1T dye to generate fluorescence, achieving wash-free and high-contrast intracellular SNVs Imaging.

Benefits of technology

The non-specific probe binding and washing process is eliminated, and the signal gain is significantly improved, and accurate detection of drug-resistant strains and acquisition of cellular heterogeneity information is achieved. It is suitable for high background tissues such as intestinal sections.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116083534B_ABST
    Figure CN116083534B_ABST
Patent Text Reader

Abstract

The present invention discloses a single base mutation imaging method using a light-up RNA aptamer, which belongs to the field of in situ detection of genes in cells. The recognition of single nucleotide site variation (SNV) is achieved through a ligase-assisted transcription reaction, and the light-up RNA aptamer is used as a reporter, which eliminates non-specific probe binding and cleaning processes, and the signal is significantly improved compared with the fluorescent in situ hybridization method. Therefore, the present invention can accurately quantify drug-resistant strains in bacterial mixtures and identify drug-resistant Salmonella isolated from poultry farms.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of in situ detection of intracellular genes, and relates to a single nucleic acid variation lighting strategy based on transcription amplification, which realizes the wash-free and high-contrast imaging of single-cell single-nucleic variation and avoids the binding of non-specific probes. The present invention can detect mutated drug-resistant strains. Background Art

[0002] Due to the excessive use of antibiotics, pathogens with drug-resistant mutations are retained, and the food safety problems caused by foodborne drug-resistant pathogens are becoming more and more serious. Therefore, it is urgent to find a method that can accurately quantify drug-resistant bacteria.

[0003] Genetic variation analysis based on PCR or sequencing has greatly advanced our understanding of the role of single nucleotide variations (SNVs) in physiological and pathological states, and some SNVs have been identified as key biomarkers for diseases such as cancer and infectious diseases. However, these batch methods based on multi-cell samples only reveal general genetic variations and characteristics of a few cells. Fluorescence in situ hybridization (FISH) has become a widely available tool for gene expression mapping at subcellular and tissue scales. In contrast, methods that image SNVs in the context of cells can provide spatial information of cellular heterogeneity and populations with single-cell resolution. However, SNV imaging is challenged by the obstacle of generating high-level signals under the requirement of single-nucleotide resolution. In order to produce high-gain cellular imaging, multi-fluorophore modified probes are usually used for target RNA labeling. Therefore, FISH cannot detect short RNA sequences and thus cannot detect SNV features in RNA. Whether coupled with nucleic acid amplification or not, FISH is inevitably accompanied by nonspecific probe binding to cellular structures or components because it relies on hybridization of fluorophore-labeled probes. Nonspecific probe binding will lead to high background and attenuated signal gain, requiring rigorous washing processes to alleviate the background.

[0004] Therefore, the present invention adopts a background-free SNV imaging strategy, using luminescent RNA aptamers as labeling probes to achieve wash-free and high-contrast imaging of intracellular SNVs detection. The method provided by this patent can accurately quantify the drug-resistant strains of Salmonella, allowing us to visualize the SNVs of Salmonella in the mouse intestine, thereby studying the colonization characteristics of drug-resistant and drug-sensitive Salmonella, and screening prebiotics to inhibit Salmonella colonization. Summary of the invention

[0005] The purpose of the present invention is to overcome the shortcomings of the prior art and explore a method for visualizing in situ detection of drug-resistant pathogen genes based on ligation-triggered transcription and luminescent aptamers to achieve non-washing and high-contrast imaging of SNVs in single cells. SNVs are identified by designing a pair of split probes and used as transcription templates. The SNVs are at the hybridization gap sites of the pair of split probes. Then, the DFHBI-1T dye generates fluorescence by binding to the transcribed Broccoli RNA, lighting up the SNVs in the cell. This method can eliminate nonspecific probe binding and washing processes, greatly reduce background, and simplify imaging protocols. In addition, this method has a higher gain for sequence images with SNVs and can be used for high-background tissue sections such as the intestine.

[0006] The specific steps of the single cell in situ detection method of the present invention are as follows:

[0007] (1) Transcription amplification imaging. After the bacteria are fixed, probe hybridization, ligation and transcription reactions are performed. A certain volume of Probe L (10 μM), Probe R (10 μM), promoter (10 μM), 20×SSC buffer, DTT (100 mM), RiboLock RNase Inhibitor (40 U / μL), yeast tRNA (10 mg / mL), formamide and RNase-free H2O are added to a centrifuge tube, and the probe is hybridized with the cell mRNA at 37°C overnight.

[0008] After washing twice with 1×PBS buffer at room temperature, T4 DNA ligase, 10×T4 DNA ligase buffer solution and water were added to react for 1 hour to connect Probe L and Probe R. Then phi 29DNA polymerase, dNTPs, 10×phi 29DNA polymerase reaction buffer solution and water were added to react at 37°C for 1 hour. After washing once with 1×PBS buffer, T7 RNA polymerase, 10×T7 RNA polymerase buffer solution, rNTPs and water were added to incubate at 37°C for 12 hours. DFHBI-1T solution (10mM) was added to bind to RNA aptamer broccoli. Fluorescence images were taken using a Nikon Ts2R-FL inverted microscope. The excitation wavelength was 490-510nm and the emission wavelength was 520-550nm.

[0009] (2) Fluorescence detection. First, mix the RNA sample, promoter (10 μM), probe L (10 μM), probe R (10 μM), T4 DNA ligase, 10×T4 DNA ligase buffer and water, and incubate at 37°C for 30 min for hybridization and ligation. Add T7 RNA polymerase, 10×T7 RNA polymerase buffer, rNTPs and water for transcription amplification. Add DFHBI-1T solution (10 mM), react at 37°C for 12 h, and then use Synergy H1 (BioTek, USA) microplate reader for fluorescence spectroscopy analysis. The excitation wavelength is 468 nm and the emission wavelength is 498 nm.

[0010] The principle of the pathogenic bacteria RNA mutation imaging method based on transcription amplification and single nucleic acid variation (SNV) lighting strategy of lighting nucleic acid aptamers described in the present invention is as follows Figure 1 As shown. Probe L and probe R are a pair of split probes used to identify SNVs and serve as transcription templates. Probe L consists of a recognition module and a promoter site, and probe R consists of a recognition module and a luminescent label. Probe L and probe R are complementary to cellular RNA. The gap site where the probe and cellular RNA hybridize is the SNV to be detected, and the ligase is highly sensitive to mismatches at the gap site. Therefore, SNVs in cellular RNA can be identified through a ligation reaction. The ligation reaction generates a template that can be transcribed, and then a large amount of Broccoli RNA is generated, which can bind to the dye DFHBI-1T to produce fluorescence and light up the SNVs in the cell. First, the 83rd position (Ser83Phe) mutation was selected as the target SNV in the quinolone resistance determining region (QRDR) of Salmonella gyrA. The hybridization and transcription process were verified by electrophoresis analysis, and its binding effect with the dye was verified by cell imaging. The results are shown in Figure 2. Figure 2 As shown. The stability of hybridization between the designed probe and cell RNA will affect the ligation efficiency and SNV discrimination. The results show that the optimal recognition module length for SNV recognition is 15nt. The light-up strategy using RNA labeling can eliminate the washing process and significantly improve the signal gain compared with the FISH method, with the signal gain enhanced by 2 times, as shown in Figure 2. Figure 3 As shown. In order to evaluate whether this method can achieve accurate quantification of drug-resistant bacteria and obtain population heterogeneity information, the present invention mixed drug-resistant Salmonella with sensitive Salmonella in various proportions, and measured the fluorescence intensity of various Salmonella to verify whether its detection of drug-resistant Salmonella is accurate. The results showed that this method can accurately quantify the heterogeneity of SNVs-related bacterial populations, and the average fluorescence intensity of various drug-resistant Salmonella is significantly higher than that of other types of Salmonella, such as Figure 4 shown.

[0011] In order to evaluate the potential of this method to visualize Salmonella with SNV genotype in intestinal sections, the present invention uses an imaging method of a light-up strategy to study the colonization of Salmonella in the cecum. Then, based on the imaging method, oligoxylose and propionate, which have the potential to inhibit intestinal colonization of Salmonella, were used to evaluate the effect of potential prebiotics on the cecal colonization of Salmonella. Compared with the control group, the colonization ability of Salmonella was significantly inhibited after the addition of oligoxylose or propionic acid. The inhibitory effect of the oligoxylose and propionic acid addition groups on the colonization of Salmonella was 1.8 times and 2.2 times that of the oligoxylose and propionic acid addition groups, respectively. The synergistic effect of oligoxylose and propionic acid can improve the inhibitory ability of Salmonella in intestinal colonization. In order to further study the antibacterial mechanism, the present invention uses RT-qPCR to detect the expression level of Salmonella genes involved in colonization. When feeding xylooligosaccharides or propionic acid, the experimental groups with sequences that affect the colonization process were all downregulated compared with the control group. Xylooligosaccharides and propionic acid can inhibit the colonization of Salmonella through multiple genetic pathways related to invasion, colonization and infection, such as Figure 5 shown.

[0012] Compared with the prior art, the present invention has the following beneficial effects:

[0013] 1. This method uses a light-up strategy of RNA labeling to eliminate the washing process and significantly improve the signal gain compared with the FISH method.

[0014] 2. This method provides a visualized in situ detection method for pathogen genes based on ligation-triggered transcription and luminescent aptamers to achieve wash-free and high-contrast imaging of SNVs in single cells, achieving accurate quantification of drug-resistant bacteria and obtaining population heterogeneity information.

[0015] 3. This method has the potential to visualize Salmonella with SNV genotypes in intestinal sections, and imaging methods can be used to study the colonization of Salmonella in the cecum. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1 A schematic diagram of a method for visualizing in situ detection of pathogenic bacteria RNA mutations based on a single nucleic acid variation (SNV) lighting strategy of transcription amplification and lighting nucleic acid aptamers provided by the present invention; Figure 2 To validate SNV calls using ligation-triggered transcription; Figure 3 Comparison of SNV imaging between FISH method and light-up strategy; Figure 4 For the quantitative study of quinolone-resistant Salmonella; Figure 5 To study the colonization of Salmonella in the mouse intestine; Figure 6 It is the sequence information of 2 probe oligonucleotides. DETAILED DESCRIPTION

[0017] The pathogenic bacteria RNA mutation imaging method based on transcription amplification and single nucleic acid variation (SNV) lighting strategy of lighting nucleic acid aptamers provided by the present invention is further described below in conjunction with examples and drawings.

[0018] Example 1: Distinguishing between drug-resistant strains and sensitive strains mixed in different proportions

[0019] In this embodiment, the mixed resistant strains and sensitive strains can be distinguished by the method proposed in the present invention. The specific operation steps are as follows: take strains of different proportions, incubate the bacteria in a lysate at 37°C for 14 hours, and centrifuge the enriched bacteria at 6000 rpm for 5 minutes. Then, remove the supernatant and resuspend in 4% paraformaldehyde for 1 hour. Then, incubate with 50μg / mL proteinase K at 37°C for 10 minutes. Add 5‰ Triton X-100 and incubate at 37°C for 5 minutes. Finally, wash with 1×PBS buffer. Mix probe L with T4 polynucleotide kinase (10U / μL), 10×T4 polynucleotide kinase reaction buffer, probe (100μM), ATP (10mM), react at 37°C for 60 minutes, and terminate at 70°C for 10 minutes. Probe L (10 μM), Probe R (10 μM), promoter (10 μM), 20×SSC buffer, DTT (100 mM), RiboLock RNase Inhibitor (40 U / μL), yeast tRNA (10 mg / mL), formamide and RNase-free H2O were added to a centrifuge tube, and the probe was hybridized with the cell mRNA at 37°C overnight.

[0020] After washing twice with 1×PBS buffer at room temperature, T4 DNA ligase, 10×T4 DNA ligase buffer solution and water were added to react for 1 hour. Phii 29 DNA polymerase, dNTPs, 10×phi 29 DNA polymerase reaction buffer solution and water were added to react at 37°C for 1 hour. After washing once with 1×PBS buffer, T7 RNA polymerase, 10×T7 RNA polymerase buffer solution, rNTPs and water were added to incubate at 37°C for 12 hours. DFHBI-1T solution (10mM) was added to bind to RNA aptamer broccoli. Fluorescence images were taken using a Nikon Ts2R-FL inverted microscope. The excitation wavelength was 490-510nm and the emission wavelength was 520-550nm.

[0021] Example 2: Detection of drug-resistant Salmonella in poultry farms

[0022] In this embodiment, the method of the present invention can be used to detect whether the Salmonella isolated from the poultry farm has mutated and has drug-resistant genes. The operation steps are as follows: the strains isolated from the farm are treated as shown in Example 1 and then imaged in situ, and finally the fluorescent images are quantitatively analyzed using Image J. The results show that the method can better distinguish between drug-resistant strains and drug-sensitive strains, such as Figure 4 shown.

[0023] Example 3: Differentiating drug-resistant and drug-sensitive strains in the cecum of mice

[0024] In this embodiment, specific pathogen-free BALB / c mice can be divided into 4 groups, 6 mice in each group. After 5 days of feeding, intestinal bacteria are removed by antibiotic treatment, 1 group is fed with oligoxylose, 1 group is fed with propionic acid, and 1 group is fed with oligoxylose and propionic acid. The control group without oligoxylose and propionic acid is used as a control. After 5 days, the mice are orally administered with Salmonella. After 3 days, the cecum is collected under sterile conditions and sliced ​​for imaging.

Claims

1. A method for non-disease diagnosis and treatment purposes based on transcription amplification and single nucleic acid variation (SNV) lighting strategy for RNA mutation imaging of single-cell single-base mutation-resistant pathogens and gastrointestinal tract drug-resistant pathogens, characterized in that The method includes two processes: mutation site recognition and signal conversion output. The SNV is recognized through a ligase-assisted transcription reaction. A lit RNA aptamer is used as a reporter probe to generate specific fluorescence, light up the target gene, eliminate non-specific probe binding and cleaning processes, connect two primers through T4 DNA ligase to form a sequence that can be used for transcription and signal conversion, and optimize the hybridization length of the primer target gene. The primer sequences used are shown in SEQ ID NO.1 and SEQ ID NO.2, and the mutation is the Ser83Phe mutation of gyrA.

2. The method according to claim 1, characterized in that The sequence was transcribed and amplified by T7 RNA polymerase, and the obtained RNA nucleic acid aptamer was combined with the specific dye DFHBI-1T to realize signal conversion. First, T4 DNA ligase, 10×T4 DNA ligase buffer solution and water were added to the hybridized product for reaction for 1 hour, and then phi 29 DNA polymerase, dNTPs, 10×phi 29 DNA polymerase reaction buffer solution and water were added thereto for reaction at 37°C for 1 hour. Then, after rinsing once with 1×PBS buffer, T7 RNA polymerase, 10×T7 RNA polymerase buffer solution, rNTPs and water were added and incubated at 37°C for 12 hours. Finally, 10 nm DFHBI-1T solution was added to combine with the RNA aptamer broccoli, wherein the excitation wavelength of the DFHBI-1T dye is 490-510 nm, and the emission wavelength is 520-550 nm.

3. The method according to claim 1, characterized in that It can realize the visual detection of single-cell single-base mutation-resistant pathogens and single-gene mutations of gastrointestinal resistant pathogens.